Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RhC antigen is a polymorphic protein component of the Rhesus (Rh) blood group system, specifically encoded by the RHCE gene (UniProt P18577). It is a multi-pass transmembrane protein expressed on the surface of erythrocytes, where it forms a complex with other Rh proteins and the Rh-associated glycoprotein (RhAG) to maintain the structural integrity of the red blood cell membrane (NCBI Gene ID: 6006). Beyond its structural role, the RhCE polypeptide is thought to function as an ammonium transporter, contributing to the maintenance of cation gradients (StatPearls: Blood Group Antigens). The RhC antigen is highly immunogenic and is a frequent cause of alloimmunization in Rh-negative individuals following transfusion or pregnancy. This immune response can lead to clinical complications such as hemolytic transfusion reactions and hemolytic disease of the fetus and newborn (HDFN), where maternal anti-C antibodies cross the placenta and destroy fetal red blood cells (PubMed: 25563499). In clinical practice, the RhC antigen is a target for diagnostic antibodies used in blood typing and is managed through the administration of intravenous immunoglobulin (IVIG) or exchange transfusions in cases of severe hemolysis.
Binding of specific antibodies to the RhC antigen on red blood cells leads to the clearance of these cells by the reticuloendothelial system, preventing or managing alloimmunization.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood group RhCE polypeptide (RhCE) (RhCE).